IPF Clinical Trial
Official title:
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of Inhaled AGMB-447 in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis
The purpose of this study is to measure the safety, tolerability PK and PD of inhaled AGMB-477 compared with placebo in healthy participants and participants with IPF. This is an integrated phase 1, single center, 3-part, double-blind, randomized, placebo-controlled SAD (Part A) and MAD (Part B) study in healthy participants and multiple dose study in IPF participants (Part C). Safety, tolerability PK and PD will be assessed following single ascending, multiple ascending and multiple dosing of AGMB-447 administered via nebulizer in Part A, B and C, respectively.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05570058 -
Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
Recruiting |
NCT02807025 -
Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
|
N/A | |
Recruiting |
NCT05895565 -
A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects
|
Phase 1 | |
Completed |
NCT03211507 -
Idiopathic Pulmonary Fibrosis Job Exposures Study
|
||
Completed |
NCT02503657 -
Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
|
Phase 2 | |
Recruiting |
NCT03873298 -
Inhaled NO in IPF and COPD During 6 Minute Walk Test
|
Phase 2 | |
Terminated |
NCT03864328 -
A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF
|
Phase 2 | |
Completed |
NCT05803850 -
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
|
Phase 1 | |
Withdrawn |
NCT05349760 -
A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
Completed |
NCT01266317 -
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
|
Phase 1/Phase 2 | |
Recruiting |
NCT05147597 -
Turkish Validity and Reliability of SGRQ-I
|
||
Completed |
NCT04503044 -
ILAs in CT Lung Cancer Screening Population
|
||
Recruiting |
NCT04564183 -
Advancing Prevention of Pulmonary Fibrosis
|
||
Recruiting |
NCT05190211 -
Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis
|
N/A | |
Recruiting |
NCT04263727 -
A Study of Patients With Chronic Disease
|
||
Completed |
NCT05353556 -
Effects of Home-based Inspiratory Muscle Training in Patients With IPF
|
N/A | |
Completed |
NCT02976935 -
Functional MR Lung Imaging Using Hyperpolarised 129Xe
|
||
Recruiting |
NCT05193136 -
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
|
||
Not yet recruiting |
NCT02885961 -
The Coagulation Cascade in Idiopathic Pulmonary Fibrosis
|
N/A | |
Completed |
NCT02151435 -
Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
|
N/A |